Loading...

ICCC IMMUCELL CORP Expansion Plans 8-K Filing

MMCL

CCC

IMMUCELL CORP

(ICCC)

2026 8-K

Settlement Agreement

Board Changes Announced

Sales Growth Report

Financial Results Release

Management Changes

Sales Results Update

Strategy Change Announcement

Financial Results Announced

Management Changes

Sales Announcement

CEO Appointment

Credit Extension Agreement

Quarterly Results

Financial Statements

Leadership Changes

Financial Statements

Sales Announcement

Management Change

Financial Results

Insurance Settlement

Sales Announcement

Management Change

Contract Amendment

Sales Announcement

Lease Amendment

Financial Results

Financial Results

Lease Amendment

Annual Meeting of Stockholders

Financial Results Announcement

Agreement for Stock Offering

Financial Results

Agreement Termination

Line of Credit Extension

Earnings Reports

Financial Results

Lease Amendment

Financial Results Announcement

Financial Results

Financial Results Announcement

Debt-Equity Swaps

Regulation FD Disclosure

Financial Results

Financial Results Announcement

Financial Results

External Links:

ImmuCell Corporation reported a 28.4% increase in product sales for Q1 2026 compared to Q1 2025, with the event date being April 8, 2026. This filing indicates a positive trend in the company’s financial performance, making it a significant event.

AI Assistant

IMMUCELL CORP

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.